2d
Clinical Trials Arena on MSNIcon integrates Medidata’s Clinical Data Studio into clinical studiesIcon has begun the integration of Medidata Clinical Data Studio into its clinical studies. This development makes Icon the ...
We recently compiled a list of the Top 8 Trending AI Stock Updates On Wall Street Today. In this article, we are going to ...
The integration of Clinical Data Studio into ICON's service offerings helps unlock the full potential of the Medidata Data Experience, merging information from both Medidata and non-Medidata sources, ...
Tears represent a clinical entity for some tendons which is distinct from tendinopathy, and which may require different management to that of tendinopathy. The ICON group defined tears as a ...
Goldman Sachs downgraded Icon (ICLR) to Neutral from Buy with a price target of $200, down from $250. While the firm continues to believe that ...
BERWYN, Pa. and DUBLIN, March 4, 2025 /PRNewswire/ -- Mural Health Technologies, Inc., a patient-first clinical trial technology company, and ICON plc (NASDAQ: ICLR), a global healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results